ChatGPT has been rejected as a co-author in scientific papers by The American College of Rheumatology (ACR) journal editors due to concerns over lack of accountability.
Epigenetic drugs that have shown promise as a cancer therapy could also be repurposed and used to treat scleroderma, an autoimmune condition characterized by cell scarring.